Wikipedia -WSS

Wikipedia

author：knowledge 2025-09-09 19:27:57 - browse：23164

European Medicines Agency Suffers Cyber Attack in Amsterdam — Paulo Amorim / VWPics via AP Images

LONDON — Two days after similar decisions in the U.S. and U.K., regulators in Europe on Friday recommended that the approval of Eli Lilly’s diabetes drug Mounjaro be widened to include obesity.

The ruling from a committee of the European Medicines Agency now goes to the European Commission, which makes the final decision but almost always follows the EMA’s guidance.

Mounjaro, known scientifically as tirzepatide, is one of an emerging class of drugs that target receptors of the GLP-1 hormone, and sometimes other molecules, and that have had dramatic effects on weight loss. Doctors have been prescribing the diabetes drugs off-label for obesity, but having specific authorization could streamline the process of getting the medicines.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： What does generative AI mean for health care? We asked experts
Next article： The biotech scorecard for Q3: 15 stock

Wikipedia

WSS

Use doctors trained outside the U.S. to ease the physician shortage

Pig kidney works a record two months in donated body

The biotech scorecard for Q3: 15 stock

Canadians with cystic fibrosis outlive Americans by a decade

Canadians with cystic fibrosis outlive Americans by a decade

STAT wants to know your pick for a great summer read or listen

focus

Wikipedia

hotspot

George Santos makes 1st court appearance after pleading not guilty to 13 counts

Vertex cell therapy lets patients with type 1 diabetes stop insulin

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

How Robert F. Kennedy Jr. distorted vaccine science

Drug repurposing or repositioning? The language matters

Will the IRA bring competition to the biologics market?

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

Telehealth for opioid use disorder is lifesaving

FDA approval of Sarepta Duchenne genetic therapy gives me hope

'Screen and refer' systems are hurting patients

leisure time

FDA panel endorses Alnylam’s heart drug — after picking it apart

Fatty liver disease was alleviated by Lilly’s ‘triple

AstraZeneca lung cancer study comes in below expectations

White House touts steps to stem shortages of cancer treatments

How housing is health care on Long Island

Diverse clinical trials: Why aren’t we there yet?

entertainment

hotspot

Wikipedia

hotspot